4
Changes in Ownership
Atea Pharmaceuticals, Inc. Filed Acc 0000950170-24-010969
EVP, Chief Accounting Officer sold 12,477 shares at $3.84 ($47,904)
- EVP, Chief Accounting Officer acquired 33,334 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Foster Wayne EVP, Chief Accounting Officer | 2024-01-31 | Option exercise | +33,334 | 33,334 | D | ||
| Foster Wayne EVP, Chief Accounting Officer | 2024-02-01 | Sale | −12,477 | $3.84 | $47,904 | 20,857 | D |
| Derivatives | |||||||
| Foster Wayne EVP, Chief Accounting Officer | 2024-01-31 | Option exercise · Restricted Stock Units | −33,334 | 66,666 | D | ||
| Foster Wayne EVP, Chief Accounting Officer | 2024-01-31 | Grant or award · Stock Option (Right to Buy) | +120,100 | 120,100 | D | ||
| Open-market sales · 12,477 sh · avg $3.84 · $47,904 | |||||||
Loading xslF345X05/ownership.xml…